SCHEMBL26259657

SCHEMBL26259657

CC(C)(C)c1ccc2c(-c3cccs3)cccc2c1-c1cccs1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.37
LTA4H P09960 1/20 0.36
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 2/20 0.35
MAPK1 P28482 1/20 0.35
MET P08581 1/20 0.35
LTK P29376 1/20 0.35
CDK5 Q00535 1/20 0.35
MST1R Q04912 1/20 0.35
DYRK1A Q13627 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
ALOX5 P09917 2/20 0.35
PTGS1 P23219 2/20 0.35
PTGS2 P35354 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12405295 0.77 KDM4E (0.46) LTA4HKDM4EALDH1A1MAPTHPGD
SCHEMBL7212806 0.77 KDM4E (0.50) LTA4HKDM4EALDH1A1MAPTHPGD
SCHEMBL9206329 0.74 LTA4H (0.47) LTA4HKDM4EALDH1A1MAPTHPGD
SCHEMBL7450150 0.71 KDM4E (0.48) ACHELTA4HKDM4EALDH1A1MAPT
SCHEMBL9927346 0.69 LTA4H (0.47) ACHELTA4HKDM4EALDH1A1MAPT
SCHEMBL29945128 0.69 LTA4H (0.47) ACHELTA4HKDM4EALDH1A1MAPT
SCHEMBL29658035 0.69 ACHE (0.56) ACHELTA4HKDM4EALDH1A1MAPT
SCHEMBL13130593 0.69 ACHE (0.56) ACHELTA4HKDM4EALDH1A1MAPT
SCHEMBL7999310 0.69 MAOA (0.46) LTA4HKDM4EALDH1A1MAPTHPGD
SCHEMBL73268 0.69 PIM1 (0.49) LTA4HKDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 ACHE 1754/4885LTA4H 1665/4885KDM4E 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.